Jane Street Group, LLC Harrow Health, Inc. Transaction History

Jane Street Group, LLC

  • $444 Billion
  • Q4 2024

A detailed history of Jane Street Group, LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 96,906 shares of HROW stock, worth $2.95 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
96,906
Previous 132,633 26.94%
Holding current value
$2.95 Million
Previous $5.96 Million 45.48%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$33.39 - $57.5 $1.19 Million - $2.05 Million
-35,727 Reduced 26.94%
96,906 $3.25 Million
Q3 2024

Nov 14, 2024
BUY
$20.85 - $46.47 $460,013 - $1.03 Million
22,063 Added 19.95%
132,633 $5.96 Million
Q2 2024

Aug 14, 2024
BUY
$10.0 - $21.64 $889,680 - $1.93 Million
88,968 Added 411.85%
110,570 $2.31 Million
Q1 2024

May 15, 2024
SELL
$9.3 - $13.23 $469,464 - $667,850
-50,480 Reduced 70.03%
21,602 $285,000
Q4 2023

Feb 14, 2024
BUY
$8.1 - $16.36 $583,864 - $1.18 Million
72,082 New
72,082 $807,000
Q2 2023

Aug 14, 2023
SELL
$17.37 - $28.08 $986,094 - $1.59 Million
-56,770 Reduced 31.05%
126,055 $2.4 Million
Q1 2023

May 15, 2023
BUY
$13.84 - $21.46 $1.59 Million - $2.47 Million
115,098 Added 169.94%
182,825 $3.87 Million
Q4 2022

Feb 14, 2023
BUY
$10.28 - $14.78 $696,233 - $1 Million
67,727 New
67,727 $999,000
Q2 2022

Aug 16, 2022
SELL
$5.75 - $7.74 $90,717 - $122,113
-15,777 Closed
0 $0
Q1 2022

May 17, 2022
BUY
$6.77 - $8.66 $106,810 - $136,628
15,777 New
15,777 $108,000
Q3 2021

Nov 16, 2021
SELL
$6.99 - $10.6 $287,414 - $435,850
-41,118 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$6.68 - $11.07 $274,668 - $455,176
41,118 New
41,118 $382,000
Q4 2020

Feb 17, 2021
SELL
$4.76 - $6.93 $48,509 - $70,623
-10,191 Closed
0 $0
Q3 2020

Nov 17, 2020
SELL
$4.71 - $7.36 $164,341 - $256,805
-34,892 Reduced 77.4%
10,191 $57,000
Q2 2020

Aug 17, 2020
BUY
$3.61 - $6.47 $21,468 - $38,477
5,947 Added 15.2%
45,083 $235,000
Q1 2020

May 15, 2020
BUY
$3.5 - $7.31 $136,976 - $286,084
39,136 New
39,136 $149,000
Q2 2019

Aug 15, 2019
SELL
$4.2 - $8.7 $73,164 - $151,554
-17,420 Closed
0 $0
Q1 2019

May 16, 2019
BUY
$4.75 - $7.1 $82,745 - $123,682
17,420 New
17,420 $87,000

Others Institutions Holding HROW

# of Institutions
184
Shares Held
21.1M
Call Options Held
679K
Put Options Held
1.27M
View Full List

About HARROW HEALTH, INC.

HROW Quotes by TradingView
  • Ticker HROW
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 27,070,000
  • Market Cap $825M
  • Description
  • Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...
More about HROW
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email